Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › AR › Paragould › NPI 1437222312
Hospital

Arkansas Methodist Hospital Corporation

Arkansas Methodist Hospital Corporation was paid $9.38M by Medicaid between Jan 2018 and Dec 2024, across 215 billing codes. Its largest line is U0002, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc — 6.0% of everything it billed.

33Billing provider infoARKANSAS METHODIST HOSPITAL CORPORATION
PARAGOULD, AR 72450
33aNPI1437222312assigned 11/16/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$9.38M
24GClaims500,962
24DCodes billed215
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Arkansas

Rank by total paid#10 of 49
Median peer was paid$2.62M
This provider vs. median3.6×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$100K$200K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201868,129$989K
201980,156$1.65M
202067,641$1.32M
202164,315$1.21M
202269,999$1.23M
202383,778$1.66M
2024incomplete66,944$1.32M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 6.0% 10,021 8,896 $560K
80053 Comprehensive metabolic panel 5.3% 41,729 35,058 $501K
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 4.8% 7,438 6,185 $449K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 4.4% 49,069 40,581 $417K
74177 Computed tomography, abdomen and pelvis; with contrast material 3.8% 2,218 2,045 $360K
59025 Fetal non-stress test 3.7% 2,111 1,337 $346K
70450 Computed tomography, head or brain; without contrast material 3.6% 2,950 2,686 $333K
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 3.3% 4,189 3,365 $306K
72148 Magnetic resonance imaging, lumbar spine; without contrast material 2.5% 795 772 $236K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 2.4% 5,617 4,637 $229K
80306 2.1% 9,711 8,252 $199K
80050 General health panel 2.0% 3,929 3,839 $190K
203 more codes
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 2.0% 5,430 $188K
84443 Thyroid stimulating hormone (TSH) 1.9% 12,318 $176K
71046 Radiologic examination, chest; 2 views 1.7% 8,394 $163K
83880 1.6% 5,293 $148K
0240U 1.5% 1,102 $140K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.2% 10,244 $116K
87086 Culture, bacterial; quantitative colony count, urine 1.2% 10,725 $109K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 1.2% 497 $109K
80061 Lipid panel 1.2% 7,549 $109K
36415 Collection of venous blood by venipuncture 1.0% 19,446 $98K
87081 <1% 9,859 $92K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 1,276 $88K
80074 <1% 1,461 $88K
72125 Computed tomography, cervical spine; without contrast material <1% 632 $87K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 1,273 $86K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 2,624 $84K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 2,402 $82K
87275 <1% 6,136 $80K
87276 <1% 6,133 $79K
51702 <1% 447 $77K
71045 Radiologic examination, chest; single view <1% 7,884 $73K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 891 $71K
80048 Basic metabolic panel (calcium, ionized) <1% 8,468 $71K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 2,453 $71K
73630 <1% 2,241 $65K
83036 Hemoglobin; glycosylated (A1C) <1% 6,382 $64K
84703 <1% 5,284 $64K
84484 <1% 5,993 $63K
81001 <1% 15,338 $60K
84439 <1% 5,160 $58K
74018 <1% 2,492 $55K
87430 <1% 4,132 $54K
82550 <1% 6,207 $53K
86703 <1% 2,896 $53K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 389 $52K
87040 <1% 4,183 $51K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 174 $51K
83735 <1% 7,112 $49K
80320 <1% 2,605 $49K
73130 <1% 1,716 $45K
83690 <1% 4,890 $45K
77067 Screening mammography, bilateral, including computer-aided detection <1% 792 $45K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 2,529 $44K
85027 <1% 5,909 $44K
82553 <1% 3,657 $43K
86901 <1% 3,094 $43K
80055 <1% 1,090 $40K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 143 $39K
73560 <1% 1,672 $39K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 272 $38K
73610 <1% 1,939 $38K
74019 <1% 1,536 $38K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 895 $37K
86803 <1% 1,910 $37K
84146 <1% 1,178 $36K
82803 <1% 1,901 $35K
80329 <1% 2,450 $35K
83605 <1% 3,078 $34K
73030 <1% 1,601 $32K
88142 <1% 1,977 $32K
73110 <1% 1,308 $32K
85730 <1% 5,603 $32K
96361 Intravenous infusion, hydration; each additional hour <1% 939 $31K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 635 $30K
82607 <1% 1,770 $29K
84702 <1% 2,356 $28K
97161 <1% 455 $28K
87088 <1% 3,161 $27K
87186 <1% 3,874 $25K
85610 <1% 6,821 $25K
86756 <1% 1,381 $24K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 1,226 $24K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 1,819 $23K
72100 <1% 937 $22K
86762 <1% 2,333 $22K
42820 Tonsillectomy and adenoidectomy; younger than age 12 <1% 50 $21K
87205 <1% 3,329 $20K
82565 <1% 2,342 $20K
72141 <1% 60 $20K
81025 <1% 2,028 $19K
87493 <1% 421 $19K
82248 <1% 2,846 $18K
85007 <1% 4,850 $18K
72131 <1% 146 $17K
73502 <1% 783 $17K
83540 <1% 2,312 $17K
81003 <1% 5,606 $16K
87070 <1% 1,489 $16K
82150 <1% 1,883 $16K
82728 <1% 1,071 $16K
51701 <1% 115 $15K
82140 <1% 1,408 $14K
86592 <1% 3,675 $14K
87210 <1% 2,112 $13K
82962 <1% 2,646 $13K
12001 <1% 47 $13K
82746 <1% 748 $12K
73562 <1% 361 $12K
88304 <1% 483 $12K
71020 <1% 850 $11K
88342 <1% 194 $11K
70486 <1% 80 $11K
86738 <1% 674 $10K
82950 <1% 1,499 $10K
83550 <1% 1,134 $10K
84520 <1% 1,774 $10K
86308 <1% 1,212 $9K
86850 <1% 2,563 $9K
86140 <1% 1,474 $9K
78227 <1% 24 $9K
82247 <1% 1,178 $8K
X4011 State-specific procedure code <1% 57 $8K
87077 <1% 742 $8K
96375 Therapeutic injection; each additional sequential IV push <1% 594 $7K
82947 <1% 1,039 $7K
87045 <1% 554 $7K
93971 <1% 134 $7K
77063 Screening digital breast tomosynthesis, bilateral <1% 395 $6K
36600 <1% 323 $6K
87340 <1% 1,602 $6K
83615 <1% 1,070 $6K
86900 <1% 2,744 $6K
74022 <1% 196 $5K
84145 <1% 284 $5K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 133 $5K
85652 <1% 1,569 $5K
73090 <1% 241 $5K
72110 <1% 132 $5K
Y7506 <1% 42 $5K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 1,949 $4K
84460 <1% 468 $4K
80076 <1% 353 $4K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia <1% 16 $4K
84450 <1% 431 $4K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 3,464 $4K
12011 <1% 13 $4K
87046 <1% 555 $3K
47562 <1% 12 $3K
87209 <1% 132 $3K
97001 <1% 54 $3K
95886 <1% 55 $3K
72040 <1% 139 $3K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 534 $2K
72128 <1% 13 $2K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 31 $2K
84112 <1% 29 $2K
74020 <1% 122 $2K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 67 $2K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 16 $2K
84550 <1% 375 $2K
71010 <1% 302 $2K
76536 <1% 39 $2K
74000 <1% 103 $2K
83525 <1% 65 $2K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 808 $2K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 14 $2K
73070 <1% 75 $1K
73590 <1% 61 $1K
82272 <1% 270 $1K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 172 $1K
86759 <1% 58 $1K
76830 Ultrasound, transvaginal <1% 13 $1K
94644 <1% 18 $979.60
72072 <1% 40 $978.15
93226 <1% 13 $948.38
82570 <1% 232 $945.05
G0202 Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (cad) when performed <1% 18 $901.12
87329 <1% 61 $815.92
87328 <1% 61 $812.73
84153 <1% 70 $802.57
80164 <1% 28 $776.06
95912 <1% 14 $722.05
82009 <1% 114 $684.89
85018 <1% 310 $518.91
J3010 Injection, fentanyl citrate, 0.1 mg <1% 279 $515.07
71101 <1% 15 $510.47
84156 <1% 117 $481.63
72050 <1% 13 $459.61
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 54 $419.29
94060 <1% 12 $381.04
73080 <1% 14 $366.13
85014 <1% 222 $355.99
73565 <1% 46 $346.82
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 12 $336.00
85651 <1% 97 $324.48
76819 Fetal biophysical profile; without non-stress testing <1% 17 $315.05
82105 <1% 12 $287.39
82951 <1% 14 $271.56
77080 <1% 12 $266.61
G0378 Hospital observation service, per hour <1% 168 $234.50
84100 <1% 202 $225.36
86430 <1% 30 $224.92
84478 <1% 32 $199.48
86038 <1% 12 $189.32
J2704 Injection, propofol, 10 mg <1% 115 $130.50
82952 <1% 14 $93.90
88300 <1% 12 $81.00
G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) <1% 73 $11.62
Q0244 Injection, casirivimab and imdevimab, 1200 mg <1% 28 $0.04
82040 0% 30 $0.00
J2250 Injection, midazolam hydrochloride, per 1 mg 0% 18 $0.00
88141 0% 21 $0.00
99152 0% 17 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSCOTT, KAY (DIRECTOR REVENUE OPERATIONS)
Same official

Other billing entities under SCOTT, KAY

Full network →
ProviderLocationPaid
Arkansas Methodist Hospital CorporationParagould, AR$4.13M
Arkansas Methodist Hospital CorporationParagould, AR$251K
Arkansas Methodist Hospital CorporationParagould, AR$142K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.